Richmond, Nov. 30, 2023 (GLOBE NEWSWIRE) -- According to a research report "Single-cell Omics Market”, By Product Type (Single-cell genomics, Single-cell transcriptomics, Single-cell proteomics, Single-cell metabolomics), Application (Oncology, Cell biology, Neurology, Immunology, Other applications), End-user (Academic and research organizations, Pharmaceutical & biotechnology companies, Hospital and diagnostic laboratories, Other end-users), and Region.
Global Single-cell Omics Market Report Scope:
| Report | Details |
| Market size value in 2022 | USD 1.66 Billion |
| Market size value in 2030 | USD 6.41 Billion |
| CAGR (2023-2030) | 18.4% |
| Forecast Period | 2023–2030 |
| Historic Data | 2019 |
| Forecast Units | Value (USD Million/USD Billion) |
| Segments Covered | Product Type, Application, End User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and RoW |
| |
| |
| Sample of Companies Covered |
|
| |
|
Download the Sample - https://www.marketdigits.com/request/sample/3652
TOC Covers in Depth & Breath on Single-cell Omics Market
180 - Market Data Tables
70 - List of Figures
238 – Pages
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.
Market Overview
Single-cell omics is an emerging area of study focused on analyzing individual cells to enhance our understanding of cellular processes, heterogeneity, and disease pathology. This sector encompasses technologies such as single-cell genomics, transcriptomics, proteomics, and epigenomics. A notable development in this field occurred in October 2022 when Illumina Inc., a leader in DNA sequencing and array-based technologies, collaborated with GenoScreen, an innovative genomics company, to accelerate efforts to eradicate tuberculosis (TB) globally. This partnership is expected to enhance the ability of TB-affected nations to identify and treat drug-resistant TB (MDR-TB), contributing to the World Health Organization's goal of eliminating the global TB epidemic by 2035. The market is primarily fueled by advancements in single-cell analysis technology and the rise of large-scale genomics studies utilizing single-cell RNA sequencing. Additionally, the rapid growth of the biotechnology and biopharmaceutical industries, coupled with the increasing demand for biologics, is driving market expansion. The upsurge in the prevalence of life-threatening conditions has further heightened the demand for personalized medicine.
Major Vendors in the Global Single-Cell Omics Market:
- 1CellBio
- Celsee, Inc.
- QIAGEN N.V
- Illumina, Inc.
- 10X Genomics, Inc.
- GE LifeSciences
- Mission Bio
- Takara Bio
- Fluidigm Corporation
- Bio-Rad Laboratories, Inc.
- NanoString Technologies, Inc.
- Fluxion Biosciences
- BGI Genomics Co. Ltd
Request for Discount @ https://www.marketdigits.com/request/discount/3652
Growing acceptance of personalized medicine.
The escalating adoption of personalized medicine has emerged as a pivotal driver for the Single-cell Omics Market. As healthcare becomes increasingly tailored to individual patient characteristics, there is a growing demand for advanced analytical techniques provided by single-cell omics technologies. These methods enable a detailed and nuanced understanding of the unique genetic, transcriptomic, proteomic, and epigenomic profiles of individual cells, facilitating precise and personalized therapeutic interventions. The emphasis on personalized medicine aligns with the goals of single-cell omics, making it an indispensable tool in the quest to unravel cellular heterogeneity, decipher intricate disease mechanisms, and develop targeted treatments tailored to the specific molecular signatures of patients. As a result, the Single-cell Omics Market is propelled by the imperative to enhance therapeutic precision and effectiveness in the era of personalized healthcare.
Market Dynamics
Drivers:
- Growing R&D spending by biopharmaceutical and biotechnology companies
- Technological advancements in single-cell analysis products
- High cost of single-cell analysis
Opportunities:
- Developing new single-cell omics technologies
- Developing software for analyzing single-cell omics data
- Developing software that can identify rare cell types from scRNA-seq data
The development of microfluidic technologies for single-cell omics experiments
A trend in the Single-cell Omics Market is the advancement of microfluidic technologies for conducting single-cell omics experiments. Microfluidic platforms offer precise control over small-scale fluid manipulation, enabling the isolation and analysis of individual cells with unprecedented accuracy and efficiency. These technologies enhance the scalability and throughput of single-cell analyses, allowing researchers to process large numbers of individual cells simultaneously. The integration of microfluidics into single-cell omics workflows streamlines processes such as cell isolation, lysis, and nucleic acid amplification, reducing sample contamination and improving data quality. This trend signifies a shift towards more sophisticated and automated methodologies, positioning microfluidic technologies as valuable contributors to the continued evolution and growth of the Single-cell Omics Market.
The market for Single-cell Omics Market is dominated by North America.
North America Region Dominated the Single-cell Omics Market. North American single-cell omics market held a substantial share of the business, and it is expected to experience significant growth during the forecast period. North America stands out as a focal point for scientific ingenuity and technological progress, creating an environment conducive to the advancement and adoption of state-of-the-art single-cell omics technologies. The region's robust concentration of market players is poised to drive market trends further. Additionally, North America's strong commitment to precision medicine and personalized healthcare aligns seamlessly with the capabilities offered by single-cell omics, leading to its increasing integration into clinical research and diagnostics. Furthermore, the presence of ample funding, strategic investments, and regulatory support for innovation serves as additional catalysts for the market's expansion in North America.
The Asia Pacific region is projected to exhibit the fastest growth, with an significant CAGR from 2023 to 2030. This growth is attributed to factors such as the escalating burden of target diseases and an increasing demand for advanced therapeutics, which are expected to propel the single-cell omics market in the region. Market players are showing a growing interest in tapping into the untapped market potential, and their increased investments in the region are contributing to the market's expansion. Furthermore, the establishment of agreements between companies to fortify their market presence is identified as another key driver for the regional market. An illustrative example is the collaboration between Mission Bio and SequMed in December 2021, wherein Mission Bio gained the opportunity to leverage its offerings in China, exemplifying the strategic initiatives fueling the growth of the market in the Asia Pacific.
Electronics Segment is Anticipated to Hold the Largest Market Share During the Forecast Period
Based on product type segment is categorized into Single-cell genomics, Single-cell transcriptomics, Single-cell proteomics, and Single-cell metabolomics. The single-cell genomics segment emerged as the primary revenue contributor, holding a substantial market share. The growth of this segment is driven by various factors, including the increasing demand from diverse end-users, the promising clinical applications of single-cell genomics platforms, and continuous technological advancements in the field. Innovations such as microfluidics, high-throughput sequencing platforms, and droplet-based methods have empowered researchers to delve into cellular heterogeneity with unprecedented precision. Furthermore, market players are actively enhancing their capabilities in single-cell level sequencing, exemplified by Singular Genomics Systems, Inc.'s February 2023 announcement of the Max Read kits for single-cell applications on their C4 sequencing platform, aiming to boost output and reduce overall experiment costs.
Simultaneously, the single-cell metabolomics segment is gaining momentum, spurred by increasing interest in metabolomics, augmented funding from government and non-government entities to expedite metabolomics research, and expanding applications in disease research. The heightened sensitivity of single-cell metabolomics in detecting cancer cells is seen as a significant driver, with the potential to propel the segment further, especially as it becomes integrated into cancer diagnostics.
Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/3652
Browse Similar Reports:
Transcriptomics Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Metabolomics Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Clinical Oncology Next-generation Sequencing Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
About MarketDigits:
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact Us:
MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com
Follow Us on: | Twitter | LinkedIn |
